Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
•
Neuro-critical care
What is your threshold for initiating tocilizumab in patients with NORSE?
Related Questions
When would you consider lacosamide for treatment of status epilepticus in patients with prolonged PR interval or first degree AV block?
How do you decide on the treatment target of burst suppression pattern vs seizure cessation for patients with status epilepticus?
When do you consider vigabatrin for the treatment of status epilepticus?
In which clinical scenarios do you obtain head and neck vascular imaging in patients with moderate to severe traumatic brain injury?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
Do you routinely check CSF cell counts and cultures on patients with external ventricular drains to monitor for infection?
What prompts you to procure EEG and/or imaging in patients presenting with multiple simple febrile seizures?
What recommendations would you make for a patient on long-term phenytoin due to epilepsy with a newly diagnosed breast cancer requiring doxorubicin as part of her chemotherapy?
Do you routinely administer desmopressin to patients with intracerebral hemorrhage who are also on anti-platelet therapy?
What is your approach to weaning phenobarbital and serial EEGs in patients with HIE after their perinatal seizures are under control?
